<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:51Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5087675" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5087675</identifier><datestamp>2016-10-31</datestamp><setSpec>biolopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biol Open</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biol Open</journal-id>
      <journal-id journal-id-type="publisher-id">BIO</journal-id>
      <journal-id journal-id-type="hwp">biolopen</journal-id>
      <journal-title-group>
        <journal-title>Biology Open</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2046-6390</issn>
      <publisher>
        <publisher-name>The Company of Biologists Ltd</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5087675</article-id>
      <article-id pub-id-type="pmcid">PMC5087675</article-id>
      <article-id pub-id-type="pmc-uid">5087675</article-id>
      <article-id pub-id-type="pmid">27628032</article-id>
      <article-id pub-id-type="pmid">27628032</article-id>
      <article-id pub-id-type="doi">10.1242/bio.018648</article-id>
      <article-id pub-id-type="publisher-id">BIO018648</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and for their fusion with lysosomes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2449-2631</contrib-id>
          <name>
            <surname>Hubert</surname>
            <given-names>Virginie</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peschel</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Langer</surname>
            <given-names>Brigitte</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GrÃ¶ger</surname>
            <given-names>Marion</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rees</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kain</surname>
            <given-names>Renate</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1"><label>1</label><institution>Clinical Institute of Pathology, Medical University of Vienna</institution>, <addr-line>Vienna</addr-line><addr-line>1090</addr-line>, <country>Austria</country></aff>
      <aff id="af2"><label>2</label><addr-line>Core Facilities</addr-line>, <institution>Medical University of Vienna</institution>, <addr-line>Vienna 1090</addr-line>, <country>Austria</country></aff>
      <author-notes>
        <corresp id="cor1"><label>*</label>Authors for correspondence (<email>virginie.hubert@meduniwien.ac.at</email>; <email>renate.kain@meduniwien.ac.at</email>)</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <day>15</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>14</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>5</volume>
      <issue>10</issue>
      <fpage>1516</fpage>
      <lpage>1529</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2016. Published by The Company of Biologists Ltd</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
        </license>
        <?release-delay 0|0?>
      </permissions>
      <self-uri content-type="pdf" xlink:href="biolopen-5-018648.pdf"/>
      <abstract>
        <title>ABSTRACT</title>
        <p>Autophagy is an evolutionarily conserved process used for removing surplus and damaged proteins and organelles from the cytoplasm. The unwanted material is incorporated into autophagosomes that eventually fuse with lysosomes, leading to the degradation of their cargo. The fusion event is mediated by the interaction between the Qa-SNARE syntaxin-17 (STX17) on autophagosomes and the R-SNARE VAMP8 on lysosomes. Cells deficient in lysosome membrane-associated protein-2 (LAMP-2) have increased numbers of autophagosomes but the underlying mechanism is poorly understood. By transfecting LAMP-2-deficient and LAMP-1/2Â­-double-deficient mouse embryonic fibroblasts (MEFs) with a tandem fluorescent-tagged LC3 we observed a failure of fusion between the autophagosomes and the lysosomes that could be rescued by complementation with LAMP-2A. Although we observed no change in expression and localization of VAMP8, its interacting partner STX17 was absent from autophagosomes of LAMP-2-deficient cells. Thus, LAMP-2 is essential for STX17 expression by the autophagosomes and this absence is sufficient to explain their failure to fuse with lysosomes. The results have clear implications for situations associated with a reduction of LAMP-2 expression.</p>
      </abstract>
      <abstract abstract-type="precis">
        <p><bold>Summary:</bold> LAMP-2 is required for autophagosome-lysosome fusion. Its absence does not affect the lysosomal SNARE VAMP8 while its interacting partner STX17 is absent from the autophagosomes providing a molecular explanation for this fusion failure.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>LAMP-2</kwd>
        <kwd>STX17</kwd>
        <kwd>Lysosome</kwd>
        <kwd>Autophagosome</kwd>
        <kwd>VAMP8</kwd>
        <kwd>Macroautophagy</kwd>
        <kwd>LC3</kwd>
      </kwd-group>
      <funding-group specific-use="FundRef">
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>Seventh Framework Programme</institution>
              <institution-id>http://dx.doi.org/10.13039/501100004963</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>FP7/2007-2013</award-id>
          <award-id>261382</award-id>
        </award-group>
      </funding-group>
      <funding-group specific-use="FundRef">
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>Vienna Science and Technology Fund</institution>
              <institution-id>http://dx.doi.org/10.13039/501100001821</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>LS09-075</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>INTRODUCTION</title>
      <p>Macroautophagy (hereafter autophagy) is characterized by unique double-membrane vacuoles that transfer surplus and damaged proteins and organelles into lysosomes for degradation. This maintains the quality of the cytoplasm and is critical for cellular homeostasis and resistance to stress. Autophagy is essential for tissue remodeling during embryogenesis and for innate and adaptive immune responses. The efficiency of autophagy declines with age and this contributes to diseases found in the elderly, including degenerative neurological disorders, autoimmune and inflammatory diseases, and tumors (<xref rid="BIO018648C45" ref-type="bibr">Mizushima et al., 2008</xref>).</p>
      <p>In mammalian cells, autophagy is mainly regulated by the level of amino acids and insulin that converge to mTOR, the main regulator of nutrient signaling (<xref rid="BIO018648C43" ref-type="bibr">Mizushima, 2007</xref>). This process is initiated at the endoplasmic reticulum (ER)-mitochondria contact sites with the development of open-ended cisterna, phagophores, which incorporate cytoplasmic components, including organelles, by engulfment (<xref rid="BIO018648C26" ref-type="bibr">Hamasaki et al., 2013</xref>) and cargo-specific loading (<xref rid="BIO018648C10" ref-type="bibr">Deretic et al., 2015</xref>). Phagophore initiation is regulated by three multiprotein complexes: the ULK1 complex comprising ULK1, autophagy-related protein 13 (Atg13), Atg101 and FIP200; the Vps 34 complex that includes Beclin1, Atg14L and Vps34; and the Atg16/Atg5/Atg12 complex. The final stage of phagophore development involves Atg3 and the incorporation of LC3 (Atg8). LC3 occurs in two forms; an unconjugated cytoplasmic form, LC3-I, and a conjugated (lipidated) form, LC3-II, that integrates into the phagophore membrane (<xref rid="BIO018648C47" ref-type="bibr">Nakatogawa et al., 2007</xref>). LC3 persists after membrane closure and leads to the formation of the autophagosomes (<xref rid="BIO018648C45" ref-type="bibr">Mizushima et al., 2008</xref>), whereas other Atg proteins and early phagophore components dissociate from mature autophagosomes (<xref rid="BIO018648C38" ref-type="bibr">KrÃ¤mer, 2013</xref>). Consequently, LC3-I and LC3-II in cell lysates have been used to monitor autophagy (<xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>). Eventually autophagosomes fuse with lysosomes to become autolysosomes.</p>
      <p>Fusion of autophagosomes with lysosomes is essential for autophagic flux and the mechanisms responsible are beginning to be understood (<xref rid="BIO018648C44" ref-type="bibr">Mizushima, 2014</xref>). They involve the interactions between numerous proteins, including some specific for autophagosome/lysosome fusion and others involved in vesicular fusion more generally. Selected vesicles and organelles are brought together both by diffusion and motor-mediated transport and then tethered to each other by specific molecular interactions. This facilitates the fusion event that occurs when a v-SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) in the membrane of one vesicle engages a t-SNARE to form a bundle of four parallel core SNARE domains that approximates the two bilayers and precipitates fusion (<xref rid="BIO018648C61" ref-type="bibr">Whyte and Munro, 2002</xref>). Tethering autophagosomes to lysosomes critically involves the Rab7 effector ORP1L and RILP, which recruits the dynein-dynactin motor and interacts with the homotypic fusion and protein sorting (HOPS) complex that consists of six subunits of vacuole sorting proteins (VPS) (<xref rid="BIO018648C1" ref-type="bibr">Balderhaar and Ungermann, 2013</xref>; <xref rid="BIO018648C29" ref-type="bibr">Hyttinen et al., 2013</xref>; <xref rid="BIO018648C62" ref-type="bibr">Wijdeven et al., 2016</xref>). This interaction is tightly regulated by the cholesterol sensor ORP1L that, under low cholesterol conditions, prevents the recruitment of HOPS to Rab7-RIPL and therefore tethering of the membrane (<xref rid="BIO018648C62" ref-type="bibr">Wijdeven et al., 2016</xref>). The HOPS complex will then tether lysosomes to autophagosomes by cross-linking Rab7 on lysosomes to syntaxin 17 (STX17) on autophagosomes (<xref rid="BIO018648C33" ref-type="bibr">Jiang et al., 2014</xref>) in a process augmented by Atg14 (<xref rid="BIO018648C1" ref-type="bibr">Balderhaar and Ungermann, 2013</xref>; <xref rid="BIO018648C11" ref-type="bibr">Diao et al., 2015</xref>). STX17 is also the Qa-SNARE essential for autophagosome-lysosome fusion. After incorporation into the autophagosome membrane, STX17 recruits the Qbc-SNARE synaptosomal-associated protein 29 (SNAP-29) and the complex is then bound by oligomeric Atg14, which primes its interaction with the R-SNARE VAMP8 on the lysosomes and induces fusion (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S1</uri>) (<xref rid="BIO018648C11" ref-type="bibr">Diao et al., 2015</xref>; <xref rid="BIO018648C30" ref-type="bibr">Itakura et al., 2012</xref>). Various other proteins have been implicated in autophagosome/lysosome fusion but their contribution is unclear (<xref rid="BIO018648C44" ref-type="bibr">Mizushima, 2014</xref>). These include lysosome membrane protein-2 (LAMP-2), a protein with a defined role in phagolysosome biogenesis as demonstrated by a failure of opsonized latex beads to stain with a lysotracker (<xref rid="BIO018648C28" ref-type="bibr">Huynh et al., 2007</xref>) in fibroblasts doubly deficient for LAMP-1 and LAMP-2. A specific role of LAMP-2 in autophagosome fusion has also been suggested but decisive proof is lacking (<xref rid="BIO018648C22" ref-type="bibr">GonzÃ¡lez-Polo et al., 2005</xref>).</p>
      <p>LAMP-2 is a heavily glycosylated type-1 membrane protein with three splice variants, LAMP-2A, LAMP-2B and LAMP-2C (<xref rid="BIO018648C5" ref-type="bibr">Carlsson et al., 1988</xref>; <xref rid="BIO018648C16" ref-type="bibr">Eskelinen et al., 2005</xref>). The three isoforms consist of a common heavily glycosylated extracellular domain linked to a single membrane spanning domain and a short cytoplasmic tail that includes a lysosomal/endosomal targeting signature and differs between the three isoforms (<xref rid="BIO018648C4" ref-type="bibr">Carlsson and Fukuda, 1989</xref>; <xref rid="BIO018648C24" ref-type="bibr">Gough and Fambrough, 1997</xref>). Over the past decade LAMP-2 has been recognized to make an important contribution to an increasing number of cellular processes. Some functions appear to be shared by all isoforms â for example antigen presentation, (<xref rid="BIO018648C64" ref-type="bibr">Zhou et al., 2005</xref>) cholesterol trafficking, (<xref rid="BIO018648C52" ref-type="bibr">Schneede et al., 2011</xref>) lysosome biogenesis (<xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>) and phagocytosis (<xref rid="BIO018648C28" ref-type="bibr">Huynh et al., 2007</xref>) â whilst others are isoform-specific. Thus, the essential role of LAMP-2 in chaperone-mediated autophagy (CMA) is unique to LAMP-2A (<xref rid="BIO018648C7" ref-type="bibr">Cuervo and Dice, 1996</xref>); only LAMP-2B contributes to retention of TAPL in the lysosomal membrane (<xref rid="BIO018648C9" ref-type="bibr">Demirel et al., 2012</xref>); and RN/DNautophagy is mediated exclusively by LAMP-2C (<xref rid="BIO018648C18" ref-type="bibr">Fujiwara et al., 2013a</xref>,<xref rid="BIO018648C19" ref-type="bibr">b</xref>). Human and murine cells deficient in LAMP-2 have increased numbers of autophagosomes, (<xref rid="BIO018648C12" ref-type="bibr">Endo et al., 2015</xref>; <xref rid="BIO018648C54" ref-type="bibr">Tanaka et al., 2000</xref>) but although previous methods such electron microscopy allow the identification of autophagosomes and autolysosomes, they could not quantify autophagic flux precluding analysis of fusion.</p>
      <p>Transfection of cells with a LC3 construct fused to an mRFP and EGFP (tfLC3) tandem fluorescent tag identifies autophagosomes and autolysosomes and clearly distinguishes between them (<xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>). We have used this construct to establish that LAMP-2-deficient mouse fibroblasts have a major defect in the degradation of autophagosomal content within the lysosome that is reversed by complementation with LAMP-2A but not LAMP-2B. Remarkably, LAMP-2 deficiency did not affect the expression of the lysosomal R-SNARE VAMP8 but instead reduced the abundance of autophagosomal STX17 to near undetectable levels, and altered recruitment of the accessory proteins required for tethering and fusion. These results identify a novel function for LAMP-2 and have obvious implications for understanding the mechanisms of autophagosomal maturation and degradation and the consequences of LAMP-2 deficiency.</p>
    </sec>
    <sec sec-type="results" id="s2">
      <title>RESULTS</title>
      <sec id="s2a">
        <title>LAMP-2 deficiency inhibits macroautophagy</title>
        <p>We first established the conditions for the induction of autophagy in a well-characterized set of SV40 transformed mouse embryonic fibroblast (MEF) cell lines derived from mice singly deficient in LAMP-2, doubly deficient in LAMP-1 and LAMP-2, and wild-type littermates, and analyzed the contribution of LAMP-2 to autophagosome-lysosome fusion (<xref rid="BIO018648C15" ref-type="bibr">Eskelinen et al., 2004</xref>). All three cell lines expressed the Simian virus 40 (SV40) large T antigen (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S2A</uri>) and LAMP-1 and LAMP-2 were undetectable by immunofluorescence and western blotting in the appropriate deficient cells line (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S2B,C</uri>). The MEF cell lines were then transiently transfected with tandem-tagged LC3 (tfLC3/mRFPâEGFPâLC3) (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>A) and autophagosomes that had incorporated tfLC3 were identified by orange fluorescence (co-localisation of mRFP and EGFP) that distinguished them from autolysosomes that fluoresce red (mRFP) because of quenching and digestion of the EGFP when exposed to lysosomal acidity and enzymes (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S2D</uri>) (<xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>). This enabled us to assess the formation and the maturation of newly synthesized autophagosomes.
<fig id="BIO018648F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>The autophagic flux is impaired in LAMP-2-single- and LAMP-1/2-double-deficient cells after autophagy induction.</bold> Cells were transfected with the tandem-fluorescent tagged mRFPâGFPâLC3 construct (A) and cultured in media (control), rapamycin (50âÂµm) (B) or HBSS (C) for 6âh. In wild-type MEFs, autophagy induction was characterized by an increased number of autophagosomes and autolysosomes (D) while in LAMP-2-single-deficient (E) and LAMP-1/2-double-deficient (F) cells the number of autolysosomes remained unchanged after treatment with rapamycin or HBSS. (G) Western blot analysis of total cell extract reveals an absence of degradation of p62 after rapamycin treatment confirming the blockage of the autophagic flux in LAMP-2-negative cells. Scale bars=10âÂµm. Data are expressed as meanÂ±s.d. of three independent experiments. *<italic>P</italic>&lt;0.05; **<italic>P</italic>&lt;0.01; ***<italic>P</italic>&lt;0.001; ****<italic>P</italic>&lt;0.0001 (MannâWhitney test).</p></caption><graphic xlink:href="biolopen-5-018648-g1"/></fig></p>
        <p>In wild-type MEFs, induction of autophagy after 6Â h incubation with rapamycin (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>B) or Hank's balanced salt solution (HBSS) (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>C) caused parallel increases in autophagosomes and autolysosomes: autophagosomes â 4.15Â±2.89 to 10.29Â±6.61 (meanÂ±s.d.) (<italic>P</italic>&lt;0.0001) and 9.00Â±7.78 (<italic>P</italic>&lt;0.01) puncta/cell pre- and post-rapamycin and HBSS respectively; autolysosomes â 2.70Â±4.37 to 9.96Â±8.31 (<italic>P</italic>&lt;0.0001) and 14.35Â±14.30 puncta/cell (<italic>P</italic>&lt;0.0001) pre- and post-rapamycin and HBSS (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>D). Rapamycin and HBSS caused the expected increase in autophagosomes in LAMP-2-deficient MEFs but without change in the number of autolysosomes (autophagosomes â 3.47Â±2.65 to 11.00Â±6.13 and 3.47Â±2.65 to 12.41Â±6.95 pre- and post-rapamycin and HBSS respectively; and autolysosomes â 5.47Â±4.67 to 3.05Â±4.21 and 6.95Â±6.68) (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>E). The results with LAMP-1/2-double-deficient MEFs were identical (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>F). Incubation with rapamycin or HBSS for 4Â h produced similar results (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S3A,B</uri>), thus confirming the failure to generate autolysomes in LAMP-2-deficient MEFs and implying a reduction in autophagic flux.</p>
        <p>We confirmed the influence of LAMP-2 on autophagic flux using western blot to examine endogenous concentrations of LC3-I and LC3-II and p62/sequestosome 1 (p62/SQSTM1), a targeting molecule incorporated into autophagosomes and degraded in autolysosomes. Under resting conditions, LC3-I and LC3-II were more abundant in the lysates from LAMP-2-deficient MEFs than wild-type cells. Incubation with rapamycin slightly increased the level of LC3-II in wild-type cells and the effect was exaggerated in LAMP-2-deficient cells, consistent with the failure to degrade LC3 II (<xref ref-type="fig" rid="BIO018648F1">Fig.Â 1</xref>G). Similarly, concentrations of p62/SQSTM1 decreased in wild-type MEFs after rapamycin treatment but remained unchanged in LAMP-2-deficient cells, indicating the failure to increase autophagic flux. Collectively, the data establish that LAMP-2-deficient cells have impaired autophagic flux characterized by a selective reduction in autolysosomes. This locates the defect at a late stage of the autophagic process.</p>
      </sec>
      <sec id="s2b">
        <title>Reconstitution with LAMP-2A restores the wild-type phenotype</title>
        <p>Next we used human LAMP-2 cDNA constructs to establish that absence of LAMP-2 was responsible for the defect in autophagosome fusion and that the human protein was able to rescue endogenous mouse LAMP-2 deficiency. To confirm the functional efficacy of the LAMP-2 constructs, cell lines were transiently transfected with a photoswitchable CMA reporter construct, pKFERQ-PS-CFP2 (<xref rid="BIO018648C37" ref-type="bibr">Koga et al., 2011</xref>) (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>A) which, after photoconversion, identifies lysosomes that have imported the reporter protein by LAMP-2A-dependent CMA as green fluorescent puncta. There were few green fluorescent puncta in wild-type MEFs incubated in complete medium, indicating a low basal level of CMA, but these increased greatly after 24âh incubation in HBSS (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>B; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S4A</uri>). By contrast, HBSS failed to increase the number of green puncta in either LAMP-2-deficient (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>B; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S4B</uri>) or LAMP-1/2-double-deficient MEFs (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>B; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S4C</uri>), demonstrating their inability perform CMA (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S1</uri>). The efficacy of the LAMP-2A construct was then evaluated by its ability to restore CMA in the deficient cell lines. This was done by transiently co-transfecting the cell lines with the photoswitchable CMA reporter construct and LAMP-2A; the effectiveness of transfection was confirmed by immunofluorescence (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S4D</uri>). Complementing with LAMP-2A completely restored the defect in CMA (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>C; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S2</uri>) and therefore confirms the functional efficacy of the construct. This enabled us to test whether restoring LAMP-2 expression was equally effective at overcoming the defect in autophagy.
<fig id="BIO018648F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>CMA and autophagic flux are restored by LAMP-2A.</bold> CMA, monitored with the photoswitchable reporter pKFERQ-PS-CFP2 (A) could be efficiently induced in wild-type cells but not in LAMP-2-single- and LAMP-1/2Â­-double-deficient MEFs indicating their inability to conduct CMA (B). This process was efficiently restored by transfection with LAMP-2A (C). Similarly, reconstitution of LAMP-2-deficient cells with LAMP-2A (D) restored the increase of autolysosomes after induction of autophagy. Results were compared to LAMP-2-deficient (E) and wild-type MEFs (F) and reveal a restoration of the autophagic flux after treatment with both rapamycin (G) or HBSS (H). Scale bars=10âÂµm. Data are expressed as meanÂ±s.d. of three independent experiments. *<italic>P</italic>&lt;0.05; **<italic>P</italic>&lt;0.01; ***<italic>P</italic>&lt;0.001; ****<italic>P</italic>&lt;0.0001 (MannâWhitney test).</p></caption><graphic xlink:href="biolopen-5-018648-g2"/></fig></p>
        <p>LAMP-2-deficient MEFs were co-transfected with tfLC3 and either LAMP-2A (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>D) or LAMP-2B (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S5A</uri>) and expression of the transgene was confirmed by indirect immunofluorescence. Using an antibody specific for hLAMP-2, the results were compared to those obtained with uncomplemented LAMP-2-deficient MEFs (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>E) and wild-type MEFs (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>F). As with CMA, complementation with LAMP-2A rectified the defect in autophagy as demonstrated by the concomitant increase in autophagosomes and autolysosomes after rapamycin treatment, both in LAMP-2-single- and LAMP-1/2-double-deficient MEFs (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>G). Autophagic flux induced by HBSS was similarly restored (<xref ref-type="fig" rid="BIO018648F2">Fig.Â 2</xref>H). By contrast, reconstitution with LAMP-2B did not rescue the autophagic flux which confirms a specific role for LAMP-2A in autophagy (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S5B,C</uri>; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TablesÂ S3, S4</uri>). However, due to an absence of a control confirming a physiological role of the LAMP-2B construct we cannot definitively exclude a possible role in autophagy.</p>
      </sec>
      <sec id="s2c">
        <title>LAMP-2 deficient cells have normal lysosome numbers and VAMP8 expression</title>
        <p>LAMP-2 is a major lysosomal membrane protein but its deficiency in the MEF cell lines, either alone or together with LAMP-1, had no effect on the number or location of lysosomes visualized with LysoTracker under resting conditions and after induction of autophagy with rapamycin or HBSS (<xref ref-type="fig" rid="BIO018648F3">Fig.Â 3</xref>A,B; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S5</uri>). We next examined whether LAMP-2 deficiency influenced the abundance of the lysosomal SNARE VAMP8.
<fig id="BIO018648F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>Lysosomal parameters are not altered in the absence of LAMP-2.</bold> (A,B) Lysosome numbers are similar in all three cell lines as is the pattern of distribution after treatment. (C,D) Expression of VAMP8 is not statistically significantly increased in LAMP-1/2-double-deficient cells. (E,F) A similar number of vesicles was observed in all cell types independent of the type of method used to induce autophagy. Scale bars=20âÂµm. (G) Immuno-electron microscopy confirms the localization of VAMP8 (15-nm gold particle, arrowheads) in the lysosomes of LAMP-2 sufficient and deficient cells grown in media or rapamycin. Scale bar=500nm. Data are expressed as meanÂ±s.d. from at least 15 cells in each condition and are representative of three independent experiments. L, lysosome.</p></caption><graphic xlink:href="biolopen-5-018648-g3"/></fig></p>
        <p>After rapamycin treatment, there was a non-significant increase of VAMP8 in the cell lysates from double deficient cell lines compared to wild-type and LAMP-2â/â MEFs (<xref ref-type="fig" rid="BIO018648F3">Fig.Â 3</xref>C,D). Despite this, the number of VAMP8-positive puncta was similar in all three cell lines, both before and after induction of autophagy with either rapamycin or HBSS for 6Â h (<xref ref-type="fig" rid="BIO018648F3">Fig.Â 3</xref>E,F) (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S6</uri>) or for 4 h (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S6A</uri>). VAMP8 co-localized with LAMP-1, indicating it was restricted to lysosomes (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S6B,C</uri>), but was not detected on LC3-positive autophagosomes (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S6D,E</uri>). The specific localization of VAMP8 was confirmed by immuno-electron microscopy (<xref ref-type="fig" rid="BIO018648F3">Fig.Â 3</xref>G; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S6F</uri>) where co-localization between the lysosomal marker LAMP-1 (15 nm gold particle) and VAMP8 (5ânm gold particle) was observed in both cell lines (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S6G</uri>). The ratio between VAMP8 and LAMP-1, established by counting 5 and 15ânm gold particles inside LAMP-1-positive vesicle was increased non-significantly in LAMP-2 deficient cells under resting conditions and after autophagy induction. This effect was due to an increased number of VAMP8 particles as LAMP-1 remains unchanged (1.167Â±0377 LAMP-1 particles/ LAMP-1+ vesicles in wild-type and 1.303Â±1.075 LAMP-1 particles/LAMP-1+ vesicles in LAMP-2 deficient cell) (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7A</uri>). Interestingly, intact VAMP8-positive lysosome-like structures were seen inside autophagosomes of LAMP-2- and LAMP-1/2-deficient MEFs (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7B</uri>). These structures also expressed LAMP-1, confirming they were lysosomes that had been incorporated during the engulfment stage. Engulfed lysosomes were not observed in wild-type MEFs but found uniquely in singly and doubly deficient cells, either because LAMP-2-deficient lysosomes are especially susceptible to autophagy or because of the reduced autophagic flux.</p>
        <p>The results were identical regardless of whether autophagy was induced by HBBS or rapamycin, making it highly unlikely that the LAMP-2-dependent defect in autophagy can be explained by an effect on VAMP8. Accordingly, we examined the effect of LAMP-2 deficiency on expression of STX17, VAMP8's interacting partner on autophagosomes.</p>
      </sec>
      <sec id="s2d">
        <title>LAMP-2 deficiency prevents STX17 localization to autophagosomes</title>
        <p>LAMP-2 deficiency had no effect on the abundance of STX17 in whole cell lysates from MEFs by western blot (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>A,B), and, as described by <xref rid="BIO018648C30" ref-type="bibr">Itakura et al. (2012)</xref> and <xref rid="BIO018648C33" ref-type="bibr">Jiang et al. (2014)</xref> it translocated to LC3+ autophagosomes in wild-type cells after induction of autophagy (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>C). Strikingly, in the absence of LAMP-2, the number of STX17-positive puncta visualized by immunocytochemistry was markedly reduced (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>D). This difference, already apparent in resting cells, was far greater after incubation with rapamycin in which STX17-positive vesicles increased in wild-type MEFs but not in the LAMP-2-deficient cell lines (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>D,E) (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S7</uri>). We confirmed that LAMP-2-deficient cells are unable to recruit STX17 to autophagosomes by transfecting cells with FLAG-tagged STX17. Ectopic expression of human STX17 (FLAGâSTX17) did not rescue STX17 translocation to LC3-positive autophagosomes (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>F) whereas reconstitution with LAMP-2A partially restored the number of STX17-positive puncta (<xref ref-type="fig" rid="BIO018648F4">Fig.Â 4</xref>G,H; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S8</uri>). However, the increase was less than in wild-type cells, possibly due to the unstable expression levels of LAMP-2A after transient transfection, or alternatively because of the absence of the two other LAMP-2 isoforms.
<fig id="BIO018648F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>STX17 is not found on the autophagosomes of LAMP-2 and LAMP-1/2 deficient cells.</bold> The amount of protein in the cell lysate of LAMP-2-deficient and -sufficient cells is similar (A,B), while the localization of STX17 is different. In wild-type cells, STX17 is recruited to LC3-positive autophagosome after autophagy induction (C), but it is not observed on the autophagosomes of single- and double-deficient cells (D,E). Transfection of wild-type and LAMP-2-deficient cells with the FLAGâStx17 construct confirms the absence of STX17 recruitment into vesicles in the absence of LAMP-2 (F). This effect could be partially restored by transfection with LAMP-2A (G,H). Scale bars=20âÂµm. Data are expressed as meanÂ±s.d. of three independent experiments. *<italic>P</italic>&lt;0.05; **<italic>P</italic>&lt;0.01; ****<italic>P</italic>&lt;0.0001 (MannâWhitney test).</p></caption><graphic xlink:href="biolopen-5-018648-g4"/></fig></p>
        <p>These results established for the first time a role of LAMP-2 in STX17 recruitment and were further confirmed by absence of STX17 co-localization on LC3-positive autophagosomes (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>A) as well as on LAMP-1-positive vesicles (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>B) in LAMP-2-deficient MEFs. In wild-type MEFs, STX17 was localized to LC3-positive vesicles (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>C) and also to rare LAMP-1-positive vesicles (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>D). Co-localization of STX17 with LC3 was significantly lower in LAMP-2-deficient cells both under resting conditions and after autophagy induction (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>E; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S9</uri>), while overlapping of STX17 with LAMP-1 was very low in both cell lines, indicating the rare presence of STX17 on LAMP-1-positive vesicles (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>F; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S10</uri>). The localization of STX17 was confirmed by immuno-electron microscopy, however STX17-positive autophagosomes were rare in single and double deficient fibroblasts (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>G). Rare co-localization was observed between LAMP-1 (15ânm gold particle)- and STX17 (5ânm gold particle)-positive vesicles in wild-type MEFs (<xref ref-type="fig" rid="BIO018648F5">Fig.Â 5</xref>H), whereas the ratio of STX17 particle/LAMP-1 particle was increased in LAMP-2-deficient cells treated with rapamycin (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7C</uri>). This was due to an increased number of STX17 particles, as the number of LAMP-1 particles remained unchanged (1.444Â±1.054 LAMP-1 particles/LAMP-1+ vesicles in wild-type and 1.221Â±0.518 LAMP-1 particles/ LAMP-1+ vesicles in LAMP-2-deficient cell). Moreover, the autophagosomes of LAMP-2- and LAMP-1/2-deficient MEFs also contained STX17-positive lysosome-like structures (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7D</uri>) that also expressed LAMP-1, and appeared identical to those observed with VAMP8 (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7B</uri>). Taking this observation into account, a ratio was established by quantifying the number of STX17 particles per LAMP-1-positive vesicles in lysosome-like structures and in normal vesicles. In LAMP-1-positive lysosome-like structure, the number of STX17 particles was significantly increased in LAMP-2-deficient cells after autophagy induction (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7E</uri>), while in intact vesicles the ratio was similar in each cell line independent of the treatment (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S7F</uri>). Thus LAMP-2 deficiency severely reduces STX17 expression on autophagosomes and this provides a potential mechanism for their failure to fuse with lysosomes.
<fig id="BIO018648F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>Localization of STX17 is affected in the absence of LAMP-2.</bold> In LAMP-2-negative fibroblasts, STX17 could not be detected on either LC3-positive autophagosomes (A) or on LAMP-1-positive vesicles (B). In wild-type MEFs, STX17 is mainly present on the autophagosomes as indicated by co-localization with LC3 (C) and occasionally on LAMP-1-positive lysosomes (D). Scale bars=20âÂµm. Using the JACoP plugin, a significant decrease of co-localization of STX17 with LC3 was observed in the absence of LAMP-2 (E), while the overlapping of STX17 with LAMP-1 was absent in both cell types (F). Immuno-electron microscopy confirms the autophagosomal localization of STX17 (15-nm gold particle, arrowheads) in wild-type MEFs (G). Due to the low number of STX17-positive particles definitive localization could not be established in LAMP-2-single- and LAMP-1/2-double-deficient cells. Scale bars=500ânm. (G). LAMP-1 and STX17 were observed in independent vesicles in wild-type MEFs. Scale bars=200ânm (H). Data are expressed as meanÂ±s.d. from at least 15 cells in each condition and are representative of three independent experiments. **<italic>P</italic>&lt;0.01; ****<italic>P</italic>&lt;0.0001 (MannâWhitney test). L, lysosomes; AP, autophagosome.</p></caption><graphic xlink:href="biolopen-5-018648-g5"/></fig></p>
      </sec>
      <sec id="s2e">
        <title>LAMP-2 deficiency prevents SNAP-29 localization to autophagosomes</title>
        <p>SNAP-29 complexes with STX17 on the surface of autophagosomes and enhances fusion by binding VAMP8 on lysosomes (<xref rid="BIO018648C30" ref-type="bibr">Itakura et al., 2012</xref>; <xref rid="BIO018648C53" ref-type="bibr">Steegmaier et al., 1998</xref>; <xref rid="BIO018648C60" ref-type="bibr">Weng et al., 2007</xref>). SNAP-29-positive puncta were rare in wild-type MEFs under resting conditions and did not co-localize with LC3 (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>A,B; <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TableÂ S11</uri>). After induction of autophagy, their number increased markedly and co-localization with LC3 was obvious (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>C) whereas co-localization with LAMP-1 was rare (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>D). By contrast, SNAP-29-positive puncta were significantly more common in LAMP-2-deficient MEFs under basal conditions but were unaffected by rapamycin treatment (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>A,B). SNAP-29 did not co-localize with LC3 (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>E) but occasional co-localization with LAMP-1 was observed and slightly increased after induction of autophagy (<xref ref-type="fig" rid="BIO018648F6">Fig.Â 6</xref>F) as confirmed by quantification of co-localization. By measuring co-localization we also confirmed that the overlapping of SNAP-29 with LC3 was decreased non-significantly in the absence of LAMP-2 (Mander's overlapping coefficient: 0077Â±0023 and 0.055Â±0028 in wild-type treated with FCS and rapamycin; 0.032Â±0.017 and 0.034Â±0.038 in LAMP-2-deficient cells pre- and post-rapamycin treatment). Thus, autophagosomes in LAMP-2-deficient MEFs fail to recruit SNAP-29 as well as STX17.
<fig id="BIO018648F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>Quantity and localization of SNAP-29</bold>-<bold>positive vesicles are altered in the absence of LAMP-2.</bold> Under basal conditions more SNAP-29-positive vesicles were observed in the absence of LAMP-2 (A,B). In wild-type MEFs, SNAP-29 co-localized with EGFPâLC3-positive vacuoles (C) and occasionally with LAMP-1 (D). In LAMP-2-deficient cells, co-localization with LC3-positive vacuoles (E) was not observed while co-localization between LAMP-1 and SNAP-29 was rare (F). Scale bars=20âÂµm. Data are expressed as meanÂ±s.d. of three independent experiments. ***<italic>P</italic>&lt;0.001(MannâWhitney test).</p></caption><graphic xlink:href="biolopen-5-018648-g6"/></fig></p>
      </sec>
      <sec id="s2f">
        <title>VPS33A does not co-localize with LC3 in LAMP-2-deficient MEFs</title>
        <p>The HOPS complex also binds to STX17 on autophagosomes and tethers them to Rab7 on lysosomes (<xref rid="BIO018648C33" ref-type="bibr">Jiang et al., 2014</xref>; <xref rid="BIO018648C39" ref-type="bibr">Lin et al., 2013</xref>) prior to fusion (<xref rid="BIO018648C59" ref-type="bibr">Wartosch et al., 2015</xref>). Accordingly, we investigated the influence of LAMP-2 deficiency on Rab7 and the HOPS complex subunit Vacuolar protein sorting-associated protein 33A (VPS33A). The three cell lines contained similar numbers of Rab7-positive puncta (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S8A,B</uri>) that also expressed LAMP-1 (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S8C,D</uri>); Rab7 did not co-localize with EGFPâLC3 (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S8E,F</uri>). As previously reported, Rab7-positive vacuoles were restricted to the perinuclear regions of wild-type and LAMP-2-deficient MEFs (<xref rid="BIO018648C15" ref-type="bibr">Eskelinen et al., 2004</xref>; <xref rid="BIO018648C31" ref-type="bibr">JÃ¤ger et al., 2004</xref>) but were more diffusely distributed in the LAMP-1/2-double-deficient cells (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S8A</uri>). Thus, Rab7 retains its normal expression in lysosomes/late endosomes in LAMP-2-single-deficient MEFs.</p>
        <p>Under resting conditions, VPS33A partially co-localized with LAMP-1 (<xref ref-type="fig" rid="BIO018648F7">Fig.Â 7A</xref>) and had a similar perinuclear distribution in wild-type and LAMP-2-deficient MEFs (<xref ref-type="fig" rid="BIO018648F7">Fig.Â 7</xref>B). In wild-type MEFs, treatment with rapamycin induced a partial redistribution of VPS33A from LAMP-1-expressing vacuoles to LC3-positive autophagosomes (<xref ref-type="fig" rid="BIO018648F7">Fig.Â 7</xref>C) but this did not occur in LAMP-2-deficient MEFs (<xref ref-type="fig" rid="BIO018648F7">Fig.Â 7</xref>D) in which co-localization of VPS33A and LC3 was reduced, albeit not significantly (Mander's overlapping coefficient: 0.115Â±0.075 and 0.105Â±0.080 in wild-type treated with FCS and rapamycin; 0.070Â±0.063 and 0.082Â±0.042 in LAMP-2-deficient cells pre- and post-rapamycin treatment). By contrast, treatment with rapamycin increased co-localization between VPS33A and LAMP-1 in the LAMP-2-deficient cells (<xref ref-type="fig" rid="BIO018648F7">Fig.Â 7</xref>E). This provides further confirmation of the functional consequences of the lack of STX17 on autophagosomes.
<fig id="BIO018648F7" orientation="portrait" position="float"><label>Fig. 7.</label><caption><p><bold>VPS33A is affected by the absence of LAMP-2.</bold> VPS33A partially co-localized with LAMP-1 in wild-type MEFs (A) observed as a perinuclear staining also in LAMP-2-deficient cells but absent in LAMP-1/2-double-deficient MEFs (B). After treatment with rapamycin VPS33A co-localized with EGFPâLC3 in wild-type (C) but not in LAMP-2â/â MEFs (D) where co-localization with LAMP-1 was increased (E). Scale bars=20âÂµm.</p></caption><graphic xlink:href="biolopen-5-018648-g7"/></fig></p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s3">
      <title>DISCUSSION</title>
      <p>LAMP-2-deficient cells contain increased numbers of autophagosomes but it has been unclear whether this is due to increased generation or their failure to fuse with lysosomes (<xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>; <xref rid="BIO018648C22" ref-type="bibr">GonzÃ¡lez-Polo et al., 2005</xref>). Using tandem fluorescent-tagged LC3, we now show unequivocally that autophagosomes in LAMP-2-deficient mouse fibroblasts fail to fuse with lysosomes, and that the defect can be reversed by complementation with LAMP-2A, although it remains uncertain whether the other two isoforms would be similarly effective. Mechanistically, LAMP-2 deficiency reduces expression of autophagosomal SNARE STX17 to nearly undetectable levels without change in the abundance of its lysosomal partner, VAMP8, thus providing a reason for the impaired fusion (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">Fig.Â S9</uri>). These results identify the translocation of SNARE proteins to autophagosomes as a previously unsuspected function for LAMP-2 with implications not only for individuals with Danon disease who are genetically deficient of LAMP-2 but also for situations, such as aging, where LAMP-2 expression is reduced.</p>
      <p>Cells from individuals (Danon disease) (<xref rid="BIO018648C48" ref-type="bibr">Nishino et al., 2000</xref>) and mice (<xref rid="BIO018648C54" ref-type="bibr">Tanaka et al., 2000</xref>) with genetic LAMP-2 deficiency have increased numbers of autophagosomes <italic>in vivo</italic>. LAMP-2-deficient cells <italic>in vitro</italic> also have increased numbers of autophagosomes but the respective contribution of enhanced or sustained formation and decreased fusion have not been clearly defined (<xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>; <xref rid="BIO018648C22" ref-type="bibr">GonzÃ¡lez-Polo et al., 2005</xref>; <xref rid="BIO018648C41" ref-type="bibr">Massey et al., 2006</xref>). The principal difficulty has been to quantify the formation and the maturation of the autophagosomes because endogenous or GFP-tagged LC3 is immediately destroyed or quenched by lysosomal enzymes and pH after fusion and is thus rendered invisible (<xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>). Additional data from electron microscopy and biochemical analysis of LC3 have not proved decisive and assays for the autophagy substrate SQSTM1/p62 were not yet available (<xref rid="BIO018648C2" ref-type="bibr">BjÃ¸rkÃ¸y et al., 2005</xref>; <xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>; <xref rid="BIO018648C28" ref-type="bibr">Huynh et al., 2007</xref>). The development of the dual-tagged tfLC3 construct (<xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>) resolved these difficulties since its mRFP red component continues to fluoresce within lysosomes, enabling the determination of whether autophagosomal cargo has been degraded. This allowed us to show clearly that autophagosomal degradation was severely inhibited in the absence of LAMP-2, and to confirm this was associated with reduced autophagic flux by immunoblotting for SQSTM1/p62. The defect was equally severe in LAMP-2-single-deficient and LAMP1/2-double-deficient cells, strongly suggesting that LAMP-2 was responsible. This is supported by the fact that the defect was reversed by complementation with LAMP-2A at levels that also restored CMA, although this does not preclude contributions from other LAMP-2 isoforms.</p>
      <p>The recent elucidation of the central components of the machinery responsible for autophagosomeâlysosome fusion provided the opportunity to examine the reasons for its failure in LAMP-2-deficient cells. Fusion depends on binding of the Qa-SNARE STX17 on the autophagosomal membrane to the lysosomal R-SNARE VAMP8 (<xref rid="BIO018648C30" ref-type="bibr">Itakura et al., 2012</xref>) in an interaction that requires the Qbc-SNARE SNAP-29 and results in the tetrameric trans-SNARE complex. The respective location of STX17 and VAMP8 to autophagosome and lysosome was first confirmed by immuno-electron microscopy. It was a surprise that deficiency of a lysosomal protein such as LAMP-2 should radically reduce STX17 expression on autophagosomes with normal, or possibly even raised VAMP8 expression on lysosomes. The absence of STX17 translocation to the autophagosomes was further supported by a reduction of STX17 co-localization with LC3 both under resting conditions and after induction of autophagy. Due to the increased numbers of autophagosomes after rapamycin treatment, co-localization of STX17 and LC3 remains unchanged under both conditions in wild-type cells. Moreover, complementation with LAMP-2A partially restores the defect, thus confirming the functional connection between LAMP-2A and STX17. However, we detected less effect of LAMP-2 deficiency on relocation of the STX17 interacting partners SNAP-29 and VPS33A to the LC3+ autophagosomes. This could either be due to technical reasons resulting from background staining with the antibodies used; or alternatively because even in the absence of their high-affinity partner STX17, SNAP-29 and VPS33A still bind to the surface of autophagosomes, albeit less efficiently. Despite a limited effect, the reduction of the Qbc SNARE SNAP-29 and HOPS complex component VPS33A on the autophagosomes supports the role of STX17 in recruiting them and identified the autophagosome as the major site of the defect. In the absence of STX17 on autophagosomes, SNAP-29 may interact and saturate its other binding partner VAMP8, explaining its lysosomal localization in LAMP-2-deficient cells. Due to saturation, induction of autophagy could not further enhance the recruitment of SNAP-29, leading to an increased number of SNAP-29-positive puncta pre- and post-rapamycin treatment. Collectively these results prove that LAMP-2 is required for normal translocation of STX17 to autophagosomes, providing the mechanism for their failure to degrade autophagosomal content.</p>
      <p>LAMP-2 is not expressed by autophagosomes and its deficiency did not influence the whole cell content of STX17. Accordingly, LAMP-2 must be critical for translocating STX17 to autophagosomal membranes, or for its retention there. In resting cells, it has been suggested that STX17 is found freely in the cytoplasm and in the endoplasmic reticulum but translocates to mature autophagosomes, utilizing a glycine zipper-like motif in its transmembrane domain that integrates into the double membrane (<xref rid="BIO018648C30" ref-type="bibr">Itakura et al., 2012</xref>). Membrane STX17 then recruits <italic>O</italic>-GlcNAcylated SNAP-29 whose availability is controlled by <italic>O</italic>-glycosylation transferase (OGT) (<xref rid="BIO018648C25" ref-type="bibr">Guo et al., 2014</xref>). SNAP-29 also interacts with syntaxin 6 (Stx6) forming a SNAP-29/Stx6 SNARE complex that may regulate autophagy (<xref rid="BIO018648C25" ref-type="bibr">Guo et al., 2014</xref>). The STX17/SNAP-29 complex is further stabilized by the incorporation of the dimeric form of Atg14 (<xref rid="BIO018648C11" ref-type="bibr">Diao et al., 2015</xref>) which also primes its interaction with VAMP8 to promote membrane fusion (<xref rid="BIO018648C11" ref-type="bibr">Diao et al., 2015</xref>). Finally, the HOPS complex may also stabilize the heterodimers STX17/SNAP-29 (<xref rid="BIO018648C33" ref-type="bibr">Jiang et al., 2014</xref>). However, control of STX17's origin or availability remained unclear.</p>
      <p>LAMP-2 is a major component of the lysosomal limiting membrane (<xref rid="BIO018648C5" ref-type="bibr">Carlsson et al., 1988</xref>; <xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>) and has important roles in maintaining its integrity, and for transporting proteins (<xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>), nucleic acids (<xref rid="BIO018648C18" ref-type="bibr">Fujiwara et al., 2013a</xref>) and cholesterol across it (<xref rid="BIO018648C15" ref-type="bibr">Eskelinen et al., 2004</xref>, <xref rid="BIO018648C14" ref-type="bibr">2003</xref>; <xref rid="BIO018648C63" ref-type="bibr">Wilke et al., 2012</xref>). LAMP-2 is absolutely required for CMA, which targets long-lived proteins for degradation (<xref rid="BIO018648C7" ref-type="bibr">Cuervo and Dice, 1996</xref>; <xref rid="BIO018648C41" ref-type="bibr">Massey et al., 2006</xref>) including inhibitors of T cell receptor signaling, which is attenuated in the absence of LAMP-2A (<xref rid="BIO018648C57" ref-type="bibr">Valdor et al., 2014</xref>); analogous degradation of putative inhibitors of STX17 translocation would provide a potential explanation. Alternatively, abrogation of LAMP-2 dependent export of cholesterol from late endosomes and lysosomes reduces cholesterol concentrations in the endoplasmic reticulum (<xref rid="BIO018648C52" ref-type="bibr">Schneede et al., 2011</xref>), which is known to alter recruitment of Stx6 (<xref rid="BIO018648C50" ref-type="bibr">Reverter et al., 2014</xref>). This in turn could affect its interaction with SNAP-29 and thus its availability to interact with STX17 (<xref rid="BIO018648C34" ref-type="bibr">Kabeya, 2000</xref>). Moreover, low levels of cholesterol in the ER and increased lysosomal cholesterol found in LAMP-2-deficient cells induce the interaction of the cholesterol sensor ORP1L with the ER protein VAP-A which prevents tethering and fusion. The ORP1L induced contact sites can modulate autophagosomes maturation and therefore potentially STX17 recruitment (<xref rid="BIO018648C62" ref-type="bibr">Wijdeven et al., 2016</xref>). More experiments are needed to test these possibilities.</p>
      <p>Leakage of lysosomal membranes and release of lysosomal hydrolases represent a potentially harmful situation for cells and damaged lysosomes may be specifically degraded by autophagy (lysophagy) as a protective measure (<xref rid="BIO018648C27" ref-type="bibr">Hung et al., 2013</xref>; <xref rid="BIO018648C40" ref-type="bibr">Maejima et al., 2013</xref>). Our data also indicate that LAMP-2 may play a role in lysophagy. The presence of LAMP-1-positive lysosomes embedded into autophagosomes of LAMP-2-deficient cells suggests either a potential role of LAMP-2 in the maintenance of the lysosomal quality and integrity or a direct contribution to autophagy-mediated lysosome turnover.</p>
      <p>In conclusion, we have shown that LAMP-2A has a critical role in recruitment to autophagosomes of STX17 and its co-factors SNAP-29 and VPS33A and thus of fusion with lysosomes. This extends the function of LAMP-2A to include macroautophagy as well as CMA. Regardless of the mechanism, our results provide a new insight into the consequences of LAMP-2 deficiency in Danon disease. They also have implications for more common situations in which LAMP-2 concentrations are reduced sufficiently to impair its function, notably in the elderly (<xref rid="BIO018648C8" ref-type="bibr">Cuervo and Dice, 2000</xref>; <xref rid="BIO018648C45" ref-type="bibr">Mizushima et al., 2008</xref>; <xref rid="BIO018648C57" ref-type="bibr">Valdor et al., 2014</xref>); and in individuals with autoantibodies to LAMP-2 and small vessel vasculitis (<xref rid="BIO018648C35" ref-type="bibr">Kain et al., 2008</xref>; <xref rid="BIO018648C49" ref-type="bibr">Peschel et al., 2014</xref>).</p>
    </sec>
    <sec sec-type="methods" id="s4">
      <title>MATERIAL AND METHODS</title>
      <sec id="s4a">
        <title>Plasmids</title>
        <p>The pEGFPâLC3, the ptfLC3 and the FLAGâStx17 construct were acquired from Addgene (plasmid 21073, plasmid 21074 and plasmid 45911, respectively). The generation of these constructs has been previously described (<xref rid="BIO018648C30" ref-type="bibr">Itakura et al., 2012</xref>; <xref rid="BIO018648C34" ref-type="bibr">Kabeya, 2000</xref>; <xref rid="BIO018648C36" ref-type="bibr">Kimura et al., 2007</xref>).</p>
        <p>The generation of the photoswitchable reporter pKFERQ-PS-CFP2 has been described by <xref rid="BIO018648C37" ref-type="bibr">Koga et al. (2011)</xref>. The following oligonucleotides, 5â²ctagcgccaccatgaaggaaactgcagcagccaagtttgagcggcagcacatggactccagcacttccgctgcg 3â² and 5â²gatccgcagcggaagtgctggagtccatgtgctgccgctcaaacttggctgctgcagtttccttcatggtggcg 3â² were directly annealed and ligated into the <italic>Nhe</italic>I and the <italic>Bam</italic>HI sites of the pPS-CFP2-N vector (Evrogen, FP802, Moscow, Russia). This sequence codes for 21 amino acids of the ribonuclease A (MKETAAAKFERQHMDSSTSAA) (accession number AAB35594).</p>
        <p>The LAMP-2A sequence (accession number NP_002285) was designed by GENEART GmbH using GeneOptimizer software. The coding sequence (0 to 1233) was based on the sequence information described by <xref rid="BIO018648C20" ref-type="bibr">Fukuda et al. (1988)</xref>. It comprises 1233 nucleotides and is bordered by 5â²<underline>ggatcc</underline>ggagatctggggaagtctgcggggtc 3â² and 5â²<underline>ctcgag</underline>ggttgcagatt 3. This introduces a BamH1 site at the 5â² end and a Xho1 site at the 3â² end (underlined). These restrictions sites were used to extract the LAMP-2A fragment and clone it into the respective cloning site of pcDNA3 (Invitrogen, Carlsbad, CA, USA).</p>
        <p>The LAMP-2B construct (accession number NP_054701) from bases â3 to 1233 was amplified from a LAMP-2B construct kindly provided by Professor Dr. Friedrich Haag, University of Hamburg, Hamburg, Germany. The PCR product generated with the primers 5â²ggatccgtcatggtgtgcttccgcctcttcccg 3â² (â3 to 24) and 5â²ttacagagtctgatatccagcataa 3â² (1208 to 1233) was subcloned into PCR 2.1 cloning vector using the TA cloning kit (Invitrogen, K2040-01) according to the manufacturer's instructions. The <italic>Xho</italic>1 and <italic>Kpn</italic>1 released fragment was then cloned into the respective cloning sites of pcDNA3.</p>
      </sec>
      <sec id="s4b">
        <title>Cells culture and transfection</title>
        <p>WT, LAMP-2â/â and LAMP-1/2â/â MEFs were a kind gift of Prof. Dr. Paul Saftig (Department of Biochemistry at the Christian-Albrechts UniversitÃ¤t Kiel, Germany). Their generation was reported previously (<xref rid="BIO018648C15" ref-type="bibr">Eskelinen et al., 2004</xref>). We uniquely selected cell lines immortalized by transfection with a plasmid containing the SV-40 large T antigen. Cells were cultured in Dulbecco's modified Eagles medium (DMEM) (Gibco, Waltham, MA, USA) supplemented with 10% fetal calf serum (Gibco) and 1% penicillin/streptomycin (Gibco).</p>
        <p>MEFs were transfected using Lipofectamine 2000 (Invitrogen, 11668019), Fugene 6 (Promega, E2691, Madison, WI, USA) according to the manufacturer instructions. Transfection of the FLAGâStx17 construct into MEFs was performed using Lipofectamine 3000 (Thermo Fisher, L3000008, Waltham, MA, USA) following manufacturer's instructions.</p>
      </sec>
      <sec id="s4c">
        <title>Autophagy induction</title>
        <p>Autophagy was induced by starvation or treatment with an mTOR inhibitor rapamycin (50âÎ¼M) (Calbiochem, 553210, San Diego, CA, USA) for 0, 4 and 6âh. For starvation, cells were washed three times with phosphate buffered saline (PBS) and incubated in HBSS (Invitrogen, 14025-092). Rapamycin treatment was added to fresh DMEM after three washings with PBS.</p>
        <p>For LC3 immunostaining, rapamycin treatment was combined with chloroquine (30âÂµM) (Sigma, C6628, St Louis, MI, USA).</p>
      </sec>
      <sec id="s4d">
        <title>Live cell imaging</title>
        <p>MEFs transfected with the photoswitchable reporter pKFERQ-PS-CFP2 were cultured in Âµ-Slide Angiogenesis (IBIDI, 81506, Planegg, Germany). The photoconversion was carried out with a confocal laser scanning microscope (Lsm 780, Carl Zeiss, Oberkochen, Germany) by applying a 405ânm diode laser, 30âmW, 63Ã objective. The photoswitching time did not exceed 5âs in plane mode. The photoconversion did not affect the viability of the cells (data not shown). After treatment pictures of the cells were acquired using confocal laser scanning microscope (Lsm 780, Carl Zeiss) equipped with 63Ã1.4NA oil objective lens, a diode laser 405ânm and an argon laser, multiline, 458ânm, 488ânm, 514ânm, at 37C and 5% CO<sub>2</sub>. Pictures were analyzed with the ZEN 2010 software (Zeiss) and the quantification was done with Fiji software (<xref rid="BIO018648C51" ref-type="bibr">Schindelin et al., 2012</xref>). Both the photoswitching and the imaging were performed in Phenol Red-free media.</p>
      </sec>
      <sec id="s4e">
        <title>Immunostaining and confocal microscopy</title>
        <p>MEFs were seeded on Âµ-Slide Angiogenesis (IBIDI, 81506) or on Âµ-Slide 8 well (IBIDI, 80826). After treatment with media, HBSS or rapamycin the cells were washed with PBS and fixed with freshly prepared 4% paraformaldehyde. MEFs transfected with FLAGâStx17 were fixed and permeabilized with ice-cold methanol (10âmin) followed by incubation with ice-cold acetone for 1âmin. After washing with PBS, cells were permeabilized (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TablesÂ S12, S13</uri>), blocked with 10% goat serum/1% donkey serum for 30âmin at room temperature and incubated with primary antibody diluted in 1% goat serum/1% donkey serum overnight at 4Â°C or 1âh at room temperature (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TablesÂ S12, S13</uri>). Similar diluent without primary antibody was used as negative control. After three washings with PBS, secondary antibody, diluted in goat/donkey serum 1% was added to the cells for 1âh at room temperature (<uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">TablesÂ S12, S13</uri>). In some staining, DAPI was used to visualize the nuclei. Cells were stored in 0.4% paraformaldehyde and analyzed using a confocal laser scanning microscope (Lsm 780, Carl Zeiss) using ZEN 2010 or ZEN 2012 software. This microscope was equipped with 63Ã1.4NA oil objective lens, a diode laser 405ânm, an argon laser, multiline, 458ânm, 488ânm, 514ânm, a DPSS-Laser 561ânm, a HeNe-laser 594ânm and a HeNe-laser 633ânm. Images analysis and quantification were performed using Fiji software.</p>
      </sec>
      <sec id="s4f">
        <title>Light microscopy</title>
        <p>MEFs were cultured in four-well chamber slides. Cells were fixed in freshly prepared 4% paraformaldehyde and stained in a Benchmark Ultra Fa Ventana (Roche, Basel, Switzerland). The following protocol was used: primary antibody 32âmin, hematoxylin 4âmin and detection with the Universal DAB Detection Kit (Ventana, 760-500, Basel, Switzerland).</p>
        <p>Pictures were acquired using an Axio Scope A1 microscope with a X40 objective equipped with an Axiocam ICc3 digital camera and an Axiovision analysis software.</p>
      </sec>
      <sec id="s4g">
        <title>Immunoelectron microscopy</title>
        <p>MEFs were seeded and cultured in Nunc cell culture Petri dishes. The fixation was performed in freshly prepared 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1âM phosphate buffer for 2âh. After three washings with PBS, agarose pellets were made (1% agarose in 0.1âM phosphate buffer) and fixed in 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1âM phosphate buffer for 30âmin. The cells were then dehydrated in ascending alcohol sequence and embedded in acrylic resin Lowicryk K4M (Polysciences, 15923, Warrington, PA, USA). After blocking with 1% chicken egg albumin, ultrathin sections were treated with rat anti-mouse LAMP-1 clone 1DB4 (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) and/or rabbit anti-VAMP8 (HPA006882, Sigma, 1:10) or rabbit anti-STX17(HPA001204, Sigma, 1:5) for 2âh. After three washings in 0.1% chicken egg albumin in 0.1âM Tris, cells were incubated for 1âh00 with goat anti-rabbit IgG conjugated to colloidal gold (15ânM) (BBInternational, EM.GAR15, Cardiff, UK) and doubly stained with 2% uranyl acetate (Ted Pella, Inc., 19481, Redding, CA, USA) and lead citrate. For double staining, goat anti-rabbit IgG conjugated to colloidal gold particle of 5ânM and goat anti-rat IgG conjugated to colloidal gold particles of 15nM were used. Sections were examined with a JEOL JEM-1200EX transmissions electron microscope.</p>
        <p>Quantitative immuno-electron microscopy was performed by counting the number of colloidal gold particles (5 and 15ânM). All quantifications were done by an observer blinded to experimental conditions.</p>
      </sec>
      <sec id="s4h">
        <title>Western blot</title>
        <p>Expression of LAMP-1, LAMP-2, actin, VAMP8 and STX17 was analyzed in MEF homogenates. Cells were collected in PBS after trypsinization, sedimented by spinning, resuspended in lysis buffer (125âmM Tris-HCl pHÂ 6.8/4% SDS/20% glycerol/200âmM DTT) and subjected to sonication. After heating for 5âmin at 95Â°C, protein fraction of MEFs was separated by a 10% SDS-PAGE (LAMP-1 and LAMP-2) or by a 10-20% Ready Gel Tris-HCl (Bio-Rad, 161-1160, Hercules, CA, USA) and transferred onto a polyvinylidene difluoride membrane. After blocking for 1âh at room temperature, the blot was incubated overnight at 4Â°C with primary antibody. Membranes were washed three times for 5âmin with TBS-Tween (0.05%) and incubated with alkaline phosphatase coupled antibody for 1âh at room temperature. After incubation with the DuoLux chemiluminescence substrate (Vector Laboratories, SK 6604, Burlingame, CA, USA) the signal was analyzed using the Lumi-Imager F1. Image processing and western blot quantification were done by using Fiji software. Results represent the quantification of at least four independent experiments and are expressed as relative to the level of the housekeeper protein actin.</p>
      </sec>
      <sec id="s4i">
        <title>Antibodies</title>
        <p>The following primary antibodies were used in this study: rat anti-mouse LAMP-1 (clone 1DB4, Developmental Studies Hybridoma Bank, Iowa City, IA, USA; <xref rid="BIO018648C28" ref-type="bibr">Huynh et al., 2007</xref>); rat anti-mouse LAMP-2 (clone ABL-93, Developmental Studies Hybridoma Bank; <xref rid="BIO018648C13" ref-type="bibr">Eskelinen et al., 2002</xref>; <xref rid="BIO018648C52" ref-type="bibr">Schneede et al., 2011</xref>); rabbit anti-SNAP-29 (Sigma, HPA031823; specificity extensively characterized by the Human Protein Atlas); rabbit anti-VAMP8 (Sigma, HPA006882; characterized by the Human Protein Atlas), rabbit anti-syntaxin17 (Sigma, HPA001204; characterized by the Human Protein Atlas; <xref rid="BIO018648C11" ref-type="bibr">Diao et al., 2015</xref>; <xref rid="BIO018648C33" ref-type="bibr">Jiang et al., 2014</xref>; <xref rid="BIO018648C46" ref-type="bibr">Muppirala et al., 2012</xref>); rabbit anti-VPS33A [C1C3] (GeneTex, GTX 119416, Taiwan; <xref rid="BIO018648C58" ref-type="bibr">van der Kant et al., 2013</xref>), goat anti-MAP LC3Î±/Î² (F-14, sc-16756, Santa Cruz, Dallas, TX, USA; immunofluorescence; <xref rid="BIO018648C21" ref-type="bibr">Gohla et al., 2007</xref>; <xref rid="BIO018648C55" ref-type="bibr">Tannous et al., 2008a</xref>,<xref rid="BIO018648C56" ref-type="bibr">b</xref>); mouse anti-SV-40 monoclonal antibody (Cell Marque, 351M-17, Rocklin, CA, USA); human LAMP-2 (clone H4B4, Developmental Studies Hybridoma Bank; <xref rid="BIO018648C49" ref-type="bibr">Peschel et al., 2014</xref>); rabbit anti-actin (Sigma, A2066; <xref rid="BIO018648C42" ref-type="bibr">Miyauchi et al., 2010</xref>); rabbit anti-p62 (Cell Signaling, 5114, Danvers, MA, USA; <xref rid="BIO018648C17" ref-type="bibr">Fang et al., 2013</xref>); rabbit anti-LC3B (Cell Signaling, 2775; western blot; <xref rid="BIO018648C65" ref-type="bibr">Zhou et al., 2012</xref>); rabbit anti-Rab7 (Cell Signaling, 9367; immunofluorescence; <xref rid="BIO018648C32" ref-type="bibr">Jean et al., 2015</xref>); rabbit anti-FLAG (Sigma, F7425; <xref rid="BIO018648C6" ref-type="bibr">Carmona-Mora et al., 2015</xref>; <xref rid="BIO018648C23" ref-type="bibr">Goodchild et al., 2015</xref>).</p>
        <p>For immunofluorescence we used the following secondary antibodies: Alexa Fluor 488 goat anti-rat IgG (Invitrogen, A-11006), Alexa Fluor 546 goat anti-rat IgG (Invitrogen, A-11081), Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen, A-11008), Alexa Fluor 647 goat anti-rabbit IgG (Invitrogen, A-21244), Alexa Fluor 405 goat anti-mouse IgG (Invitrogen, A-31553), Alexa Fluor 546 goat anti-mouse IgG (Invitrogen, A-11003), Alexa Fluor 594 donkey anti-rabbit IgG (Thermo Fisher, A-21207), Alexa Fluor 488 donkey anti-goat IgG (Thermo Fisher, A-11055). Anti-rat IgG-AP conjugate (Promega, S3831) and anti-rabbit IgG-AP conjugate (Promega, S3738) were used for western blot.</p>
      </sec>
      <sec id="s4j">
        <title>Quantification of lysosomes</title>
        <p>Lysosomes were labeled with LysoTracker (LysoTracker Red DND-99, Invitrogen, L7528). Briefly, the cells, cultured in a Âµ-slide angiogenesis (IBIDI, 81506) were treated with rapamycin or HBSS for 0, 4 and 6âh. Then 50ânM of LysoTracker was added to the media for 30âmin at 37Â°C and the cells were fixed in freshly prepared 4% paraformaldehyde in PBS. The number of lysosomes was evaluated using a particle counting plugin in Fiji software.</p>
      </sec>
      <sec id="s4k">
        <title>Image analysis</title>
        <p>Positively transfected cells were identified by eye. For each quantification, a region of interest of one cell was delineated including the cytoplasm and excluding the nucleus. All quantifications were performed by an observer blinded to experimental conditions.</p>
        <p>Quantification of mRFP/EGFP colocalization was performed by using the plugin âColoc 2'on the Fiji software.</p>
        <p>The number of EGFP-positive and mRFP-positive puncta observed after transfection with ptfLC3 were quantified using the function 3D Object Counter v2.0 on the Fiji software. Similar size filter was applied through the whole experiment while the threshold was determined individually by a blinded experimenter; the transient transfection leading to various level of expression.</p>
        <p>The number of EGFP-positive puncta in fibroblast transfected with the photoswitchable reporter pKFERQ-PS-CFP2 was counted by eye.</p>
        <p>Quantification of the positive vesicles stained with a LysoTracker or by immunofluorescence was operated by a counting plugin with filters for threshold and size, adapted for each experiment. Similar filters were applied for each condition inside each experiment.</p>
        <p>Quantitative co-localization analysis evaluating the proportion of SNAP-29/STX17/VPS33A colocalizing with LAMP-1/LC3 was performed over the entire fluorescence images using the Fidji's plugin âJACoPâ (Just Another Colocalization Plugin; <xref rid="BIO018648C3" ref-type="bibr">Bolte and Cordelieres, 2006</xref>).</p>
      </sec>
      <sec id="s4l">
        <title>Statistical analysis</title>
        <p>The statistical significance of the CMA experiment was evaluated by a one-way ANOVA followed by a Student's <italic>t</italic>-test. The other experiments were analyzed using a non-parametrical KruskalâWallis test followed by a MannâWhitney test when appropriate. Values are presented as meanÂ±s.d. All statistical calculations were performed using GraphPad Prism software.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Professor Paul Saftig (University of Kiel, Kiel, Germany) for the provision of LAMP-2- and LAMP-1/2-deficient cell lines and Professor Dr. Friedrich Haag (University of Hamburg, Hamburg, Germany), Professor Eisuke Itakura (University of Cambridge, Cambridge, UK) and Professor Tamotsu Yoshimori (University of Osaka, Osaka, Japan) for sharing cDNA constructs of LAMP-2, of FLAGâStx17 (Addgene plasmid 45911), of pEGFP-LC3 (Addgene plasmid 21073) and of ptfLC3 (Addgene plasmid 21074).</p>
    </ack>
    <fn-group>
      <title>Footnotes</title>
      <fn fn-type="COI-statement">
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare no competing or financial interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Author contributions</bold>
        </p>
        <p>Conceptualization: V.H., R.K. and A.R. Methodology: V.H. and R.K. Software: M.G. Validation: V.H. and A.R. Formal Analysis: V.H. and A.P. Investigation: V.H., A.P. and B.L. Resources: R.K. Data Curation: A.P. Writing-original draft preparation: V.H., R.K. and A.R. Writing-review and editing: V.H., R.K. and A.R. Visualization: V.H. and R.K. Supervision: R.K. and A.R. Project administration: V.H., A.P. and R.K. Funding acquisition: R.K. and A.R.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>
          <bold>Funding</bold>
        </p>
        <p>The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) [grant agreement number 261382 (INTRICATE)], and was supported by the Wiener Wissenschafts Forschungs und Technologiefonds (WWTF) (Vienna Science and Technology Fund) [project number LS09-075].</p>
      </fn>
      <fn fn-type="supplementary-material">
        <p>
          <bold>Supplementary information</bold>
        </p>
        <p>Supplementary information available online at <uri xlink:href="http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental">http://bio.biologists.org/lookup/doi/10.1242/bio.018648.supplemental</uri></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="BIO018648C1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balderhaar</surname><given-names>H. J. K.</given-names></name> and <name name-style="western"><surname>Ungermann</surname><given-names>C (</given-names></name></person-group><year>2013</year>). <article-title>CORVET and HOPS tethering complexes-coordinators of endosome and lysosome fusion</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>126</volume>, <fpage>1307</fpage>-<lpage>1316</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.107805</pub-id><pub-id pub-id-type="pmid">23645161</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>BjÃ¸rkÃ¸y</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lamark</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Brech</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Outzen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Perander</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ãvervatn</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Stenmark</surname><given-names>H (</given-names></name></person-group><year>2005</year>). <article-title>p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</article-title>. <source><italic>J. Cell Biol.</italic></source>
<volume>171</volume>, <fpage>603</fpage>-<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200507002</pub-id><pub-id pub-id-type="pmid">16286508</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bolte</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>CordeliÃ¨res</surname><given-names>F. P (</given-names></name></person-group><year>2006</year>). <article-title>A guided tour into subcellular colocalisation analysis in light microscopy</article-title>. <source><italic>J. Microsc.</italic></source>
<volume>224</volume>, 2<fpage>13</fpage>-<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2818.2006.01706.x</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlsson</surname><given-names>S. R.</given-names></name> and <name name-style="western"><surname>Fukuda</surname><given-names>M (</given-names></name></person-group><year>1989</year>). <article-title>Structure of human lysosomal membrane glycoprotein 1</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>264</volume>, <fpage>20526</fpage>-<lpage>20531</lpage>.<pub-id pub-id-type="pmid">2584229</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carlsson</surname><given-names>S. R.</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Piller</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Fukuda</surname><given-names>M</given-names></name></person-group> (<year>1988</year>). <article-title>Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp- 1 and h-lamp-2</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>263</volume>, <fpage>18911</fpage>-<lpage>18919</lpage>.<pub-id pub-id-type="pmid">3143719</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmona-Mora</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Widagdo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tomasetig</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Canales</surname><given-names>C. P.</given-names></name>, <name name-style="western"><surname>Cha</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Alshawaf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dottori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Whan</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Hardeman</surname><given-names>E. C.</given-names></name><etal>et al. (</etal></person-group><year>2015</year>). <article-title>The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation</article-title>. <source><italic>Hum. Genet.</italic></source>
<volume>134</volume>, <fpage>1099</fpage>-<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-015-1591-0</pub-id><pub-id pub-id-type="pmid">26275350</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuervo</surname><given-names>A. M.</given-names></name> and <name name-style="western"><surname>Dice</surname><given-names>J. F (</given-names></name></person-group><year>1996</year>). <article-title>A receptor for the selective uptake and degradation of proteins by lysosomes</article-title>. <source><italic>Science</italic></source>
<volume>273</volume>, <fpage>501</fpage>-<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1126/science.273.5274.501</pub-id><pub-id pub-id-type="pmid">8662539</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuervo</surname><given-names>A. M.</given-names></name> and <name name-style="western"><surname>Dice</surname><given-names>J. F (</given-names></name></person-group><year>2000</year>). <article-title>Age-related decline in chaperone-mediated autophagy</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>275</volume>, <fpage>31505</fpage>-<lpage>31513</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M002102200</pub-id><pub-id pub-id-type="pmid">10806201</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demirel</surname><given-names>Ã.</given-names></name>, <name name-style="western"><surname>Jan</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Wolters</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Blanz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Saftig</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>TampÃ©</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Abele</surname><given-names>R (</given-names></name></person-group><year>2012</year>). <article-title>The lysosomal polypeptide transporter TAPL is stabilized by interaction with LAMP-1 and LAMP-2</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>125</volume>, <fpage>4230</fpage>-<lpage>4240</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.087346</pub-id><pub-id pub-id-type="pmid">22641697</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deretic</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Timmins</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Moseley</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Chauhan</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Mandell</surname><given-names>M (</given-names></name></person-group><year>2015</year>). <article-title>Immunologic manifestations of autophagy</article-title>. <source><italic>J. Clin. Invest.</italic></source>
<volume>125</volume>, <fpage>75</fpage>-<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1172/JCI73945</pub-id><pub-id pub-id-type="pmid">25654553</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Wilz</surname><given-names>L. M.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vivona</surname><given-names>S.</given-names></name><etal>et al. (</etal></person-group><year>2015</year>). <article-title>ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes</article-title>. <source><italic>Nature</italic></source>
<volume>520</volume>, <fpage>563</fpage>-<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1038/nature14147</pub-id><pub-id pub-id-type="pmid">25686604</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Endo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Furuta</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Nishino</surname><given-names>I (</given-names></name></person-group><year>2015</year>). <article-title>Danon disease: a phenotypic expression of LAMP-2 deficiency</article-title>. <source><italic>Acta Neuropathol.</italic></source>
<volume>129</volume>, <fpage>391</fpage>-<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-015-1385-4</pub-id><pub-id pub-id-type="pmid">25589223</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Illert</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Schwarzmann</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Blanz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Von Figura</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Saftig</surname><given-names>P (</given-names></name></person-group><year>2002</year>). <article-title>Role of LAMP-2 in lysosome biogenensis and autophagy</article-title>. <source><italic>Mol. Biol. Cell</italic></source>
<volume>13</volume>, <fpage>3355</fpage>-<lpage>3368</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E02-02-0114</pub-id><pub-id pub-id-type="pmid">12221139</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Saftig</surname><given-names>P (</given-names></name></person-group><year>2003</year>). <article-title>At the acidic edge: emerging functions for lysosomal membrane proteins</article-title>. <source><italic>Trends Cell Biol.</italic></source>
<volume>13</volume>, <fpage>137</fpage>-<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/S0962-8924(03)00005-9</pub-id><pub-id pub-id-type="pmid">12628346</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>C. K.</given-names></name>, <name name-style="western"><surname>Neu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Willenborg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fuertes</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Salvador</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>LÃ¼llmann-Rauch</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Heeren</surname><given-names>J.</given-names></name><etal>et al. (</etal></person-group><year>2004</year>). <article-title>Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts</article-title>. <source><italic>Mol. Biol. Cell</italic></source>
<volume>15</volume>, <fpage>3132</fpage>-<lpage>3145</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E04-02-0103</pub-id><pub-id pub-id-type="pmid">15121881</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Cuervo</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>M. R. G.</given-names></name>, <name name-style="western"><surname>Nishino</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Blum</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Dice</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Sandoval</surname><given-names>I. V.</given-names></name>, <name name-style="western"><surname>Lippincott-Schwartz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>August</surname><given-names>J. T.</given-names></name> and <name name-style="western"><surname>Saftig</surname><given-names>P (</given-names></name></person-group><year>2005</year>). <article-title>Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2</article-title>. <source><italic>Traffic</italic></source>
<volume>6</volume>, <fpage>1058</fpage>-<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00337.x</pub-id><pub-id pub-id-type="pmid">16190986</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dahmen</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Dirsch</surname><given-names>O (</given-names></name></person-group><year>2013</year>). <article-title>Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase</article-title>. <source><italic>Cell Death Dis.</italic></source>
<volume>4</volume>, <fpage>e694</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2013.225</pub-id><pub-id pub-id-type="pmid">23807223</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujiwara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Furuta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kikuchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Aizawa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hatanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Konya</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tamai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>K.</given-names></name><etal>et al. (</etal></person-group><year>2013a</year>). <article-title>Discovery of a novel type of autophagy targeting RNA</article-title>. <source><italic>Autophagy</italic></source>
<volume>9</volume>, <fpage>403</fpage>-<lpage>409</lpage>. <pub-id pub-id-type="doi">10.4161/auto.23002</pub-id><pub-id pub-id-type="pmid">23291500</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fujiwara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kikuchi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Aizawa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Furuta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hatanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Konya</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Kabuta</surname><given-names>T (</given-names></name></person-group><year>2013b</year>). <article-title>Direct uptake and degradation of DNA by lysosomes</article-title>. <source><italic>Autophagy</italic></source>
<volume>9</volume>, <fpage>1167</fpage>-<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.4161/auto.24880</pub-id><pub-id pub-id-type="pmid">23839276</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukuda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Viitalas</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Matteson</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Carlsson</surname><given-names>S. R (</given-names></name></person-group><year>1988</year>). <article-title>Cloning of cDNAs encoding human lysosomal membrane</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>263</volume>, <fpage>18920</fpage>-<lpage>18928</lpage>.<pub-id pub-id-type="pmid">3198605</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gohla</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Klement</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Piekorz</surname><given-names>R. P.</given-names></name>, <name name-style="western"><surname>Pexa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>vom Dahl</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Spicher</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dreval</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>HÃ¤ussinger</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Birnbaumer</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>NÃ¼rnberg</surname><given-names>B (</given-names></name></person-group><year>2007</year>). <article-title>An obligatory requirement for the heterotrimeric G protein Gi3 in the antiautophagic action of insulin in the liver</article-title>. <source><italic>Proc. Natl. Acad. Sci. USA</italic></source>
<volume>104</volume>, <fpage>3003</fpage>-<lpage>3008</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0611434104</pub-id><pub-id pub-id-type="pmid">17296938</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>GonzÃ¡lez-Polo</surname><given-names>R.-A.</given-names></name>, <name name-style="western"><surname>Boya</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Pauleau</surname><given-names>A.-L.</given-names></name>, <name name-style="western"><surname>Jalil</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Larochette</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>SouquÃ¨re</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Pierron</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Saftig</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Kroemer</surname><given-names>G (</given-names></name></person-group><year>2005</year>). <article-title>The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>118</volume>, <fpage>3091</fpage>-<lpage>3102</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02447</pub-id><pub-id pub-id-type="pmid">15985464</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodchild</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Buchwalter</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Naismith</surname><given-names>T. V.</given-names></name>, <name name-style="western"><surname>Holbrook</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Billion</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Dauer</surname><given-names>W. T.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>C.-C.</given-names></name>, <name name-style="western"><surname>Dear</surname><given-names>M. L.</given-names></name> and <name name-style="western"><surname>Hanson</surname><given-names>P. I (</given-names></name></person-group><year>2015</year>). <article-title>Access of torsinA to the inner nuclear membrane is activity dependent and regulated in the endoplasmic reticulum</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>128</volume>, <fpage>2854</fpage>-<lpage>2865</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.167452</pub-id><pub-id pub-id-type="pmid">26092934</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gough</surname><given-names>N. R.</given-names></name> and <name name-style="western"><surname>Fambrough</surname><given-names>D. M (</given-names></name></person-group><year>1997</year>). <article-title>Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue</article-title>. <source><italic>J. Cell Biol.</italic></source>
<volume>137</volume>, <fpage>1161</fpage>-<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.137.5.1161</pub-id><pub-id pub-id-type="pmid">9166415</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>KovÃ¡cs</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><etal>et al. (</etal></person-group><year>2014</year>). <article-title>O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation</article-title>. <source><italic>Nat. Cell Biol.</italic></source>
<volume>16</volume>, <fpage>1217</fpage>-<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3066</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamasaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Furuta</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Matsuda</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Nezu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fujita</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Oomori</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Noda</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Haraguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hiraoka</surname><given-names>Y.</given-names></name><etal>et al. (</etal></person-group><year>2013</year>). <article-title>Autophagosomes form at ER-mitochondria contact sites</article-title>. <source><italic>Nature</italic></source>
<volume>495</volume>, <fpage>389</fpage>-<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/nature11910</pub-id><pub-id pub-id-type="pmid">23455425</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>Y.-H.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L. M.-W.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J.-Y.</given-names></name> and <name name-style="western"><surname>Yang</surname><given-names>W. Y (</given-names></name></person-group><year>2013</year>). <article-title>Spatiotemporally controlled induction of autophagy-mediated lysosome turnover</article-title>. <source><italic>Nat. Commun.</italic></source>
<volume>4</volume>, <fpage>2111</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms3111</pub-id><pub-id pub-id-type="pmid">23817530</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huynh</surname><given-names>K. K.</given-names></name>, <name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>C. C.</given-names></name>, <name name-style="western"><surname>Malevanets</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Saftig</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Grinstein</surname><given-names>S (</given-names></name></person-group><year>2007</year>). <article-title>LAMP proteins are required for fusion of lysosomes with phagosomes</article-title>. <source><italic>EMBO J.</italic></source>
<volume>26</volume>, <fpage>313</fpage>-<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601511</pub-id><pub-id pub-id-type="pmid">17245426</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyttinen</surname><given-names>J. M. T.</given-names></name>, <name name-style="western"><surname>Niittykoski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Salminen</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Kaarniranta</surname><given-names>K (</given-names></name></person-group><year>2013</year>). <article-title>Maturation of autophagosomes and endosomes: a key role for Rab7</article-title>. <source><italic>Biochim. Biophys. Acta-Mol. Cell Res.</italic></source>
<volume>1833</volume>, <fpage>503</fpage>-<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.11.018</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itakura</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kishi-Itakura</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Mizushima</surname><given-names>N (</given-names></name></person-group><year>2012</year>). <article-title>The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes</article-title>. <source><italic>Cell</italic></source>
<volume>151</volume>, <fpage>1256</fpage>-<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.11.001</pub-id><pub-id pub-id-type="pmid">23217709</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>JÃ¤ger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bucci</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Tanida</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kominami</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Saftig</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Eskelinen</surname><given-names>E.-L (</given-names></name></person-group><year>2004</year>). <article-title>Role for Rab7 in maturation of late autophagic vacuoles</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>117</volume>, <fpage>4837</fpage>-<lpage>4848</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.01370</pub-id><pub-id pub-id-type="pmid">15340014</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jean</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nassari</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kiger</surname><given-names>A. A (</given-names></name></person-group><year>2015</year>). <article-title>Starvation-induced MTMR 13 and RAB 21 activity regulates VAMP 8 to promote autophagosomeâlysosome fusion</article-title>. <source><italic>EMBO Rep.</italic></source>
<volume>16</volume>, <fpage>297</fpage>-<lpage>311</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201439464</pub-id><pub-id pub-id-type="pmid">25648148</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sakamaki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Itakura</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hatta</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Natsume</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Mizushima</surname><given-names>N (</given-names></name></person-group><year>2014</year>). <article-title>The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17</article-title>. <source><italic>Mol. Biol. Cell</italic></source>
<volume>25</volume>, <fpage>1327</fpage>-<lpage>1337</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E13-08-0447</pub-id><pub-id pub-id-type="pmid">24554770</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kabeya</surname><given-names>Y (</given-names></name></person-group><year>2000</year>). <article-title>LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</article-title>. <source><italic>EMBO J.</italic></source>
<volume>19</volume>, <fpage>5720</fpage>-<lpage>5728</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.21.5720</pub-id><pub-id pub-id-type="pmid">11060023</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kain</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Exner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brandes</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ziebermayr</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Alderson</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Davidovits</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Raab</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Jahn</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ashour</surname><given-names>O.</given-names></name><etal>et al. (</etal></person-group><year>2008</year>). <article-title>Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis</article-title>. <source><italic>Nat. Med.</italic></source>
<volume>14</volume>, <fpage>1088</fpage>-<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1038/nm.1874</pub-id><pub-id pub-id-type="pmid">18836458</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Noda</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Yoshimori</surname><given-names>T (</given-names></name></person-group><year>2007</year>). <article-title>Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3</article-title>. <source><italic>Autophagy</italic></source>
<volume>3</volume>, <fpage>452</fpage>-<lpage>460</lpage>. <pub-id pub-id-type="doi">10.4161/auto.4451</pub-id><pub-id pub-id-type="pmid">17534139</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koga</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Martinez-Vicente</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Macian</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Verkhusha</surname><given-names>V. V.</given-names></name> and <name name-style="western"><surname>Cuervo</surname><given-names>A. M (</given-names></name></person-group><year>2011</year>). <article-title>A photoconvertible fluorescent reporter to track chaperone-mediated autophagy</article-title>. <source><italic>Nat. Commun.</italic></source>
<volume>2</volume>, <fpage>386</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms1393</pub-id><pub-id pub-id-type="pmid">21750540</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>KrÃ¤mer</surname><given-names>H (</given-names></name></person-group><year>2013</year>). <article-title>Route to destruction: autophagosomes SNARE lysosomes</article-title>. <source><italic>J. Cell Biol.</italic></source>
<volume>201</volume>, <fpage>495</fpage>-<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201304065</pub-id><pub-id pub-id-type="pmid">23671308</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yun</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Akazawa</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>W.</given-names></name><etal>et al. (</etal></person-group><year>2013</year>). <article-title>RILP interacts with HOPS complex via VPS41 subunit to regulate endocytic trafficking</article-title>. <source><italic>Sci. Rep.</italic></source>
<volume>4</volume>, <fpage>1</fpage>-<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/srep07282</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maejima</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Omori</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kimura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Takabatake</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Saitoh</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hamasaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Noda</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Isaka</surname><given-names>Y.</given-names></name><etal>et al. (</etal></person-group><year>2013</year>). <article-title>Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury</article-title>. <source><italic>EMBO J.</italic></source>
<volume>32</volume>, <fpage>2336</fpage>-<lpage>2347</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2013.171</pub-id><pub-id pub-id-type="pmid">23921551</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Massey</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Kaushik</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sovak</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Kiffin</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Cuervo</surname><given-names>A. M (</given-names></name></person-group><year>2006</year>). <article-title>Consequences of the selective blockage of chaperone-mediated autophagy</article-title>. <source><italic>Proc. Natl. Acad. Sci. USA</italic></source>
<volume>103</volume>, <fpage>5805</fpage>-<lpage>5810</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0507436103</pub-id><pub-id pub-id-type="pmid">16585521</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyauchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ninomiya</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sakamoto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hoshi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Morioka</surname><given-names>H.</given-names></name><etal>et al. (</etal></person-group><year>2010</year>). <article-title>The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>207</volume>, <fpage>751</fpage>-<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20091957</pub-id><pub-id pub-id-type="pmid">20368579</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizushima</surname><given-names>N (</given-names></name></person-group><year>2007</year>). <article-title>Autophagy: process and function</article-title>. <source><italic>Genes Dev.</italic></source>
<volume>21</volume>, <fpage>2861</fpage>-<lpage>2873</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1599207</pub-id><pub-id pub-id-type="pmid">18006683</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizushima</surname><given-names>N (</given-names></name></person-group><year>2014</year>). <article-title>Sugar modification inhibits autophagosomeâlysosome fusion</article-title>. <source><italic>Nat. Publ. Gr.</italic></source>
<volume>16</volume>, <fpage>1132</fpage>-<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3078</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizushima</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Cuervo</surname><given-names>A. M.</given-names></name> and <name name-style="western"><surname>Klionsky</surname><given-names>D. J (</given-names></name></person-group><year>2008</year>). <article-title>Autophagy fights disease through cellular self-digestion</article-title>. <source><italic>Nature</italic></source>
<volume>451</volume>, <fpage>1069</fpage>-<lpage>1075</lpage>. <pub-id pub-id-type="doi">10.1038/nature06639</pub-id><pub-id pub-id-type="pmid">18305538</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muppirala</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>V.</given-names></name> and <name name-style="western"><surname>Swarup</surname><given-names>G (</given-names></name></person-group><year>2012</year>). <article-title>Tyrosine phosphorylation of a SNARE protein, Syntaxin 17: implications for membrane trafficking in the early secretory pathway</article-title>. <source><italic>Biochim. Biophys. Acta-Mol. Cell Res.</italic></source>
<volume>1823</volume>, <fpage>2109</fpage>-<lpage>2119</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.09.003</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakatogawa</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ichimura</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Ohsumi</surname><given-names>Y (</given-names></name></person-group><year>2007</year>). <article-title>Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion</article-title>. <source><italic>Cell</italic></source>
<volume>130</volume>, <fpage>165</fpage>-<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.05.021</pub-id><pub-id pub-id-type="pmid">17632063</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishino</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tanji</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shimojo</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Koori</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mora</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Riggs</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Koga</surname><given-names>Y.</given-names></name><etal>et al. (</etal></person-group><year>2000</year>). <article-title>Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)</article-title>. <source><italic>Nature</italic></source>
<volume>406</volume>, <fpage>906</fpage>-<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1038/35022604</pub-id><pub-id pub-id-type="pmid">10972294</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peschel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Basu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Benharkou</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brandes</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dieckmann</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>A. J.</given-names></name> and <name name-style="western"><surname>Kain</surname><given-names>R (</given-names></name></person-group><year>2014</year>). <article-title>Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN</article-title>. <source><italic>J. Am. Soc. Nephrol.</italic></source>
<volume>25</volume>, <fpage>455</fpage>-<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2013030320</pub-id><pub-id pub-id-type="pmid">24203998</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reverter</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rentero</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Garcia-Melero</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hoque</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>VilÃ  de Muga</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ãlvarez-Guaita</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Conway</surname><given-names>J. R. W.</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cairns</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lykopoulou</surname><given-names>L.</given-names></name><etal>et al. (</etal></person-group><year>2014</year>). <article-title>Cholesterol regulates Syntaxin 6 trafficking at trans-golgi network endosomal boundaries</article-title>. <source><italic>Cell Rep.</italic></source>
<volume>7</volume>, <fpage>883</fpage>-<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.043</pub-id><pub-id pub-id-type="pmid">24746815</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schindelin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Arganda-Carreras</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Frise</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kaynig</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Longair</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pietzsch</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Preibisch</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rueden</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Saalfeld</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>)<etal>.</etal>
<article-title>Fiji: an open-source platform for biological-image analysis</article-title><etal>.</etal>
<source><italic>Nat. Methods</italic></source>
<volume>9</volume>, <fpage>676</fpage>-<lpage>682</lpage><etal>.</etal>
<pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneede</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>C. K.</given-names></name>, <name name-style="western"><surname>HÃ¶lttÃ¤-Vuori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Heeren</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Willenborg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Blanz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Domanskyy</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Breiden</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Brodesser</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Landgrebe</surname><given-names>J.</given-names></name><etal>et al. (</etal></person-group><year>2011</year>). <article-title>Role for LAMP-2 in endosomal cholesterol transport</article-title>. <source><italic>J. Cell. Mol. Med.</italic></source>
<volume>15</volume>, <fpage>280</fpage>-<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2009.00973.x</pub-id><pub-id pub-id-type="pmid">19929948</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steegmaier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>J.-S.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Scheller</surname><given-names>R. H (</given-names></name></person-group><year>1998</year>). <article-title>Three novel proteins of the syntaxin/SNAP-25 family</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>273</volume>, <fpage>34171</fpage>-<lpage>34179</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.51.34171</pub-id><pub-id pub-id-type="pmid">9852078</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Guhde</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Suter</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Eskelinen</surname><given-names>E.-L.</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>LÃ¼llmann-Rauch</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>P. M. L.</given-names></name>, <name name-style="western"><surname>Blanz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>von Figura</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Saftig</surname><given-names>P (</given-names></name></person-group><year>2000</year>). <article-title>Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice</article-title>. <source><italic>Nature</italic></source>
<volume>406</volume>, <fpage>902</fpage>-<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1038/35022595</pub-id><pub-id pub-id-type="pmid">10972293</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tannous</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Johnstone</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Shelton</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Rajasekaran</surname><given-names>N. S.</given-names></name>, <name name-style="western"><surname>Benjamin</surname><given-names>I. J.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gerard</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rothermel</surname><given-names>B. A.</given-names></name><etal>et al. (</etal></person-group><year>2008a</year>). <article-title>Autophagy is an adaptive response in desmin-related cardiomyopathy</article-title>. <source><italic>Proc. Natl. Acad. Sci. USA</italic></source>
<volume>105</volume>, <fpage>9745</fpage>-<lpage>9750</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706802105</pub-id><pub-id pub-id-type="pmid">18621691</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tannous</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nemchenko</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Berry</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Johnstone</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Shelton</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>F. J.</given-names></name>, <name name-style="western"><surname>Rothermel</surname><given-names>B. A.</given-names></name> and <name name-style="western"><surname>Hill</surname><given-names>J. A (</given-names></name></person-group><year>2008b</year>). <article-title>Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy</article-title>. <source><italic>Circulation</italic></source>
<volume>117</volume>, <fpage>3070</fpage>-<lpage>3078</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.763870</pub-id><pub-id pub-id-type="pmid">18541737</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valdor</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mocholi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Botbol</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Guerrero-Ros</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Chandra</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Koga</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gravekamp</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cuervo</surname><given-names>A. M.</given-names></name> and <name name-style="western"><surname>Macian</surname><given-names>F (</given-names></name></person-group><year>2014</year>). <article-title>Chaperone-mediated autophagy regulates T cell responses through targeted degradation of negative regulators of T cell activation</article-title>. <source><italic>Nat. Immunol.</italic></source>
<volume>15</volume>, <fpage>1046</fpage>-<lpage>1054</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3003</pub-id><pub-id pub-id-type="pmid">25263126</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Kant</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Fish</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Krom</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Brummelkamp</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Carette</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rocha</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Neefjes</surname><given-names>J (</given-names></name></person-group><year>2013</year>). <article-title>Late endosomal transport and tethering are coupled processes controlled by RILP and the cholesterol sensor ORP1L</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>126</volume>, <fpage>3462</fpage>-<lpage>3474</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.129270</pub-id><pub-id pub-id-type="pmid">23729732</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wartosch</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>GÃ¼nesdogan</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Graham</surname><given-names>S. C.</given-names></name> and <name name-style="western"><surname>Luzio</surname><given-names>J. P (</given-names></name></person-group><year>2015</year>). <article-title>Recruitment of VPS33A to HOPS by VPS16 is required for lysosome fusion with endosomes and autophagosomes</article-title>. <source><italic>Traffic</italic></source>
<volume>16</volume>, <fpage>1</fpage>-<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/tra.12283</pub-id><pub-id pub-id-type="pmid">25243850</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>D. D. H.</given-names></name> and <name name-style="western"><surname>Groblewski</surname><given-names>G. E (</given-names></name></person-group><year>2007</year>). <article-title>Pancreatic acinar cells express vesicle-associated membrane protein 2- and 8-specific populations of zymogen granules with distinct and overlapping roles in secretion</article-title>. <source><italic>J. Biol. Chem.</italic></source>
<volume>282</volume>, <fpage>9635</fpage>-<lpage>9645</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M611108200</pub-id><pub-id pub-id-type="pmid">17272274</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whyte</surname><given-names>J. R. C.</given-names></name> and <name name-style="western"><surname>Munro</surname><given-names>S (</given-names></name></person-group><year>2002</year>). <article-title>Vesicle tethering complexes in membrane traffic</article-title>. <source><italic>J. Cell Sci.</italic></source>
<volume>115</volume>, <fpage>2627</fpage>-<lpage>2637</lpage>.<pub-id pub-id-type="pmid">12077354</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wijdeven</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nahidiazar</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Jalink</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Berlin</surname><given-names>I.</given-names></name> and <name name-style="western"><surname>Neefjes</surname><given-names>J (</given-names></name></person-group><year>2016</year>). <article-title>Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway</article-title>. <source><italic>Nat. Commun.</italic></source>
<volume>7</volume>, <fpage>11808</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms11808</pub-id><pub-id pub-id-type="pmid">27283760</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilke</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Krausze</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>BÃ¼ssow</surname><given-names>K (</given-names></name></person-group><year>2012</year>). <article-title>Crystal structure of the conserved domain of the DC lysosomal associated membrane protein: implications for the lysosomal glycocalyx</article-title>. <source><italic>BMC Biol.</italic></source>
<volume>10</volume>, <fpage>1</fpage>-<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/1741-7007-10-62</pub-id><pub-id pub-id-type="pmid">22214525</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lott</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Hislop</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Canaday</surname><given-names>D. H.</given-names></name>, <name name-style="western"><surname>Brutkiewicz</surname><given-names>R. R.</given-names></name> and <name name-style="western"><surname>Blum</surname><given-names>J. S (</given-names></name></person-group><year>2005</year>). <article-title>Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens</article-title>. <source><italic>Immunity</italic></source>
<volume>22</volume>, <fpage>571</fpage>-<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2005.03.009</pub-id><pub-id pub-id-type="pmid">15894275</pub-id></mixed-citation>
      </ref>
      <ref id="BIO018648C65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name><etal>et al. (</etal></person-group><year>2012</year>). <article-title>FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway</article-title>. <source><italic>Autophagy</italic></source>
<volume>8</volume>, <fpage>1712</fpage>-<lpage>1723</lpage>. <pub-id pub-id-type="doi">10.4161/auto.21830</pub-id><pub-id pub-id-type="pmid">22931788</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>